Smoothing the development path
Successful regulatory approvals are built on strong evidence-based decision-making at key points along the development path.
With wide-ranging experience across therapeutic areas for every stage of the development process, we offer statistics and programming support for all types of clinical development programme.
We can either augment in-house statistics teams or provide full biostatistics services to smooth the path to regulatory approval.
Transforming the application of Precision Medicine
We are a global leader in leading-edge statistical and computational methods to expedite Precision Medicine (Stratified Medicine) approaches, supporting biomarker discovery and validation, companion diagnostics development and the integration of biomarkers into development programmes.
With KerusCloud, we accelerate Precision Medicine and biomarker enrichment studies with state-of-the art simulation for comprehensive study optimisation and multiple subgroup identification and treatment selection.
Integrating real-world data into development programmes
We can exploit real-world data (RWD) sources to deliver clinical insight throughout development programmes, harnessing real-world evidence (RWE) to drive better healthcare decision-making.
When you subscribe to our mailing list, you’ll receive links to product data sheets including those shown below. Exploristics will use the information you provide to keep you updated about our products by email. However, your information will not be shared, and you can unsubscribe at any time.
Alternatively you can get in touch with us directly.